| NCT Number | NCT05353816 |
| Lead Sponsor | Shenzhen Core Medical Technology CO.,LTD. |
| Conditions | End-stage Heart Failure |
| Enrollment | 50 participants |
| Start Date | 2022-01-26 |
| Primary Completion | 2024-09-30 (estimated) |
| Study Completion | 2027-10-01 (estimated) |
| Updated on ClinicalTrials.gov | 2026-02-02 |